Caisse de Depot et Placement du Quebec (CDPQ)’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-399,648
| Closed | -$44.2M | – | 575 |
|
|
2025
Q1 | $44.2M | Sell |
399,648
-348,711
| -47% | -$38.6M | 0.09% | 218 |
|
|
2024
Q4 | $102M | Buy |
748,359
+11,449
| +2% | +$1.56M | 0.21% | 112 |
|
|
2024
Q3 | $84.9M | Buy |
736,910
+80,792
| +12% | +$9.31M | 0.17% | 144 |
|
|
2024
Q2 | $90.3M | Buy |
656,118
+504,435
| +333% | +$69.4M | 0.22% | 113 |
|
|
2024
Q1 | $20.9M | Buy |
151,683
+76,938
| +103% | +$10.6M | 0.05% | 250 |
|
|
2023
Q4 | $9.85M | Buy |
74,745
+14,156
| +23% | +$1.87M | 0.03% | 295 |
|
|
2023
Q3 | $6.82M | Sell |
60,589
-108,080
| -64% | -$12.2M | 0.02% | 311 |
|
|
2023
Q2 | $15.9M | Sell |
168,669
-173,763
| -51% | -$16.4M | 0.04% | 267 |
|
|
2023
Q1 | $34.7M | Buy |
342,432
+298,056
| +672% | +$30.2M | 0.1% | 192 |
|
|
2022
Q4 | $5.3M | Buy |
44,376
+21,500
| +94% | +$2.57M | 0.02% | 395 |
|
|
2022
Q3 | $2.43M | Buy |
22,876
+20,623
| +915% | +$2.19M | 0.01% | 423 |
|
|
2022
Q2 | $220K | Sell |
2,253
-22,516
| -91% | -$2.2M | ﹤0.01% | 572 |
|
|
2022
Q1 | $2.32M | Buy |
24,769
+6,800
| +38% | +$637K | 0.01% | 494 |
|
|
2021
Q4 | $1.53M | Sell |
17,969
-1,300
| -7% | -$111K | ﹤0.01% | 472 |
|
|
2021
Q3 | $1.85M | Buy |
19,269
+4,000
| +26% | +$384K | ﹤0.01% | 443 |
|
|
2021
Q2 | $1.49M | Buy |
+15,269
| New | +$1.49M | ﹤0.01% | 430 |
|